Skip to main content

Advertisement

SpringerLink
Log in

Salivary biomarkers for oral cancer and pre-cancer screening: a review

  • Review
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objective

The objective of the study was to conduct a systematic review of the literature assessing potential salivary biomarkers of oral cancer and pre-cancer and discuss emerging issues and challenges in relation to oral cancer and pre-cancer diagnostics.

Materials and methods

Search for articles involved the Medline, PubMed, and EMBASE. Specific terms were used from January 1995 to March 2017 by three experts.

Results

This search collected 270 articles, of which 105 articles such as reviews, case reports, news, letter to editor, etc. in first round and 117 articles such as publications in other languages than English, non-human studies, etc. were excluded. The remaining 48 articles considered analyzing whole saliva as well as specific gland saliva. Thirty-one studies considered oral stimuli such as eating, drinking, and oral hygiene practices for varied periods of time prior to sample collection. The time of collection of saliva was morning in most studies, but the exact time of collection was not mentioned. Three studies showed to have evaluated the whole saliva without centrifugation. Two-dimensional gel electrophoresis and tandem mass spectrometry were the most commonly used methods. Most of the potential salivary biomarkers of oral cancer are salivary proteins.

Conclusion

Combination approach of salivary biomarkers could be used as screening tool to improve early detection and diagnostic precision of oral pre-cancer and cancer.

Clinical relevance

The current findings are of importance for clinicians and researchers to mitigate the challenges in salivary-based diagnosis of oral cancer and to evaluate reliable, specific, and sensitive salivary biomarkers for oral pre-cancer and cancer diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45(4-5):309–316. https://doi.org/10.1016/j.oraloncology.2008.06.002

    Article  PubMed  Google Scholar 

  2. Byakodi R, Byakodi S, Hiremath S, Byakodi J, Adaki S, Marathe K, Mahind P (2012) Oral cancer in India: an epidemiologic and clinical review. J Community Health 37(2):316–319. https://doi.org/10.1007/s10900-011-9447-6

    Article  PubMed  Google Scholar 

  3. Llewellyn C, Johnson N, Warnakulasuriya KAA (2001) Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol 37(5):401–418. https://doi.org/10.1016/S1368-8375(00)00135-4

    Article  PubMed  Google Scholar 

  4. Scheifele C, Reichart PA (2003) Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 39(5):470–475. https://doi.org/10.1016/S1368-8375(03)00006-X

    Article  PubMed  Google Scholar 

  5. Messadi DV (2013) Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci 5(2):59–65. https://doi.org/10.1038/ijos.2013.24

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lumerman H, Freedman P, Kerpel S (1995) Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg, Oral Med Oral Pathol Oral Radiol Endod 79(3):321–329. https://doi.org/10.1016/S1079-2104(05)80226-4

    Article  Google Scholar 

  7. Mashberg A (2000) Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration. Oral Oncol 36(3):253–255. https://doi.org/10.1016/S1368-8375(00)00006-3

    Article  PubMed  Google Scholar 

  8. Mignogna MD, Fedele S, Lo RL, Ruoppo E, Lo ML (2001) Oral and pharyngeal cancer: lack of prevention and early detection by health care providers. Eur J Cancer Prev 10(4):381–383. https://doi.org/10.1097/00008469-200108000-00014

    Article  PubMed  Google Scholar 

  9. Rosin MP, Poh CF, Guillard M et al (2007) Visualization and other emerging technologies as change makers for oral cancer prevention. Ann N Y Acad Sci 1098(1):167–183. https://doi.org/10.1196/annals.1384.039

    Article  PubMed  Google Scholar 

  10. Patton LL, Epstein JB, Kerr AR (2008) Adjunctive techniques for oral cancer examination and lesion diagnosis. J Am Dent Assoc 139(7):896–905. https://doi.org/10.14219/jada.archive.2008.0276

    Article  PubMed  Google Scholar 

  11. Zimmermann BG, Wong DT (2008) Salivary mRNA targets for cancer diagnostics. Oral Oncol 44(5):425–429. https://doi.org/10.1016/j.oraloncology.2007.09.009

    Article  PubMed  Google Scholar 

  12. Zhang A, Sun H, Wang X (2012) Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl Biochem Biotechnol 168(6):1718–1727. https://doi.org/10.1007/s12010-012-9891-5

    Article  PubMed  Google Scholar 

  13. Chiappin S, Antonelli G, Gatti R, De Palo EF (2007) Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 383(1-2):30–40. https://doi.org/10.1016/j.cca.2007.04.011

    Article  PubMed  Google Scholar 

  14. Bandhakavi S, Stone MD, Onsongo G, Van Riper SK, Griffin TJ (2009) A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J Proteome Res 8(12):5590–5600. https://doi.org/10.1021/pr900675w

    Article  PubMed  PubMed Central  Google Scholar 

  15. Rai B (2008) Salivary levels vitamin E and C in different histological grading of oral cancer. Pesqui Bras Odontopediatria Clin Integr 8(1):123–125. https://doi.org/10.4034/1519.0501.2008.0081.0022

    Article  Google Scholar 

  16. Wong DT (2006) Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 137(3):313–321. https://doi.org/10.14219/jada.archive.2006.0180

    Article  PubMed  Google Scholar 

  17. Zimmermann BG, Park NJ, Wong DT (2007) Genomic targets in saliva. Ann N Y Acad Sci 1098(1):184–191. https://doi.org/10.1196/annals.1384.002

    Article  PubMed  PubMed Central  Google Scholar 

  18. Rai B, Kharb S, Jain R, Anand SC (2006) Salivary lipid peroxidation product malonaldehyde in various dental diseases. World Med J 1:100–101

  19. Rai B, Kharb S, Jain R, Anand SC (2008) Salivary vitamin E and C in lichen planus. World Med J 6:5–6

  20. Rai B, Kaur J, Jacobs R, Anand SC (2011) Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. Clin Oral Investig 15(3):347–349. https://doi.org/10.1007/s00784-010-0404-z

    Article  PubMed  Google Scholar 

  21. Cheng Y-S, Rees T, Wright J (2014) A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med 3(1):3. https://doi.org/10.1186/2001-1326-3-3

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wu J-Y, Yi C, Chung H-R, Wang D-J, Chang W-C, Lee S-Y, Lin CT, Yang YC, Yang WCV (2010) Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 46(4):226–231. https://doi.org/10.1016/j.oraloncology.2010.01.007

    Article  PubMed  Google Scholar 

  23. Lopes S, Rosas B, Koch W, Carvalho C, Wu L, Califano J, et al.(2001) Promoter hypermethylation patterns of p16, O 6 protein kinase in tumors and saliva of head and neck cancer patients. 939–942

  24. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and genetics of head and neck tumours. WHO Classif Tumour 9:163–175

    Google Scholar 

  25. de Jong EP, Xie H, Onsongo G, Stone MD, Chen X-B, Kooren JA, Refsland EW, Griffin RJ, Ondrey FG, Wu B, Le CT, Rhodus NL, Carlis JV, Griffin TJ (2010) Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One 5(6):e11148. https://doi.org/10.1371/journal.pone.0011148

    Article  PubMed  PubMed Central  Google Scholar 

  26. Streckfus CF, Dubinsky WP (2007) Proteomic analysis of saliva for cancer diagnosis. Expert Rev Proteomics 4(3):329–32

  27. Messana I, Inzitari R, Fanali C, Cabras T, Castagnola M (2008) Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us? J Sep Sci 31(11):1948–1963. https://doi.org/10.1002/jssc.200800100

    Article  PubMed  Google Scholar 

  28. Nobbs AH, Jenkinson HF, Jakubovics NS (2011) Critical Reviews in Oral Biology & Medicine. J Dent Res 90(11):1271–1278. https://doi.org/10.1177/0022034511399096

    Article  PubMed  PubMed Central  Google Scholar 

  29. Caporossi L, Santoro A, Papaleo B (2010) Saliva as an analytical matrix: state of the art and application for biomonitoring. Biomarkers 15(6):475–487. https://doi.org/10.3109/1354750X.2010.481364

    Article  PubMed  Google Scholar 

  30. Mohamed R, Campbell J-L, Cooper-White J, Dimeski G, Punyadeera C (2012) The impact of saliva collection and processing methods on CRP, IgE, and myoglobin immunoassays. Clin Transl Med 1(1):19. https://doi.org/10.1186/2001-1326-1-19

    Article  PubMed  PubMed Central  Google Scholar 

  31. Schipper R, Loof A, De Groot J, Harthoorn L, Van Heerde W, Dransfield E (2007) Salivary protein/peptide profiling with SELDI-TOF-MS. Ann N Y Acad Sci 1098(1):498–503. https://doi.org/10.1196/annals.1384.010

    Article  PubMed  Google Scholar 

  32. Al-Tarawneh SK, Border MB, Dibble CF, Bencharit S (2011) Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review. Omi A J Integr Biol 15(6):353–361. https://doi.org/10.1089/omi.2010.0134

    Article  Google Scholar 

  33. Rai B, Kaur J, Jacobs R, Singh J (2010) Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci 52(2):251–256. https://doi.org/10.2334/josnusd.52.251

    Article  PubMed  Google Scholar 

  34. Hu CW, Huang YJ, Li YJ, Chao MR (2010) Correlation between concentrations of 8-oxo-7,8-dihydro-2′-deoxyguanosine in urine, plasma and saliva measured by on-line solid-phase extraction LC-MS/MS. Clin Chim Acta 411(17-18):1218–1222. https://doi.org/10.1016/j.cca.2010.04.029

    Article  PubMed  Google Scholar 

  35. Camisasca DR, da Rós GL, Soares MR, Sandim V, Nogueira FC, Garcia CH et al (2017) A proteomic approach to compare saliva from individuals with and without oral leukoplakia. J Proteome 151:43–52. https://doi.org/10.1016/j.jprot.2016.07.029

    Article  Google Scholar 

  36. Michailidou E, Tzimagiorgis G, Chatzopoulou F, Vahtsevanos K, Antoniadis K, Kouidou S (2016) Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia. Cancer Epidemiol 43:112–118. https://doi.org/10.1016/j.canep.2016.04.011

    Article  PubMed  Google Scholar 

  37. Ghallab NA, Shaker OG (2017) Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig 21(3):937–947. https://doi.org/10.1007/s00784-016-1846-8

    Article  PubMed  Google Scholar 

  38. Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, Elashoff D, Wei R, Loo JA, Wong DT (2008) Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14(19):6246–6252. https://doi.org/10.1158/1078-0432.CCR-07-5037

    Article  PubMed  PubMed Central  Google Scholar 

  39. Mizukawa N, Sugiyama K, Fukunaga J, Ueno T, Mishima K, Takagi S, Sugahara T (1998) Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res 18(6B):4645–4649

    PubMed  Google Scholar 

  40. Murakami Y, Kubo S, Tamori A, Itami S, Kawamura E, Iwaisako K, Ikeda K, Kawada N, Ochiya T, Taguchi Y (2015) Comprehensive analysis of transcriptome and metabolome analysis in intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Sci Rep 5(1):16294. https://doi.org/10.1038/srep16294

    Article  PubMed  PubMed Central  Google Scholar 

  41. Wang Q, Gao P, Wang X, Duan Y (2014) The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics. Sci Rep 4:6802. https://doi.org/10.1038/srep06802

Download references

Author information

Authors and Affiliations

  1. OMFS IMPATH research group, Department Imaging & Pathology, Faculty of Medicine, KU Leuven and Oral and Maxillofacial Surgery, University Hospitals Leuven, Leuven, Belgium

    J Kaur, R Jacobs, Y Huang, N Salvo & C Politis

  2. State Key Laboratory of Oral Diseases, West China College of Stomatology, Sichuan University, Chengdu, China

    Y Huang

Authors
  1. J Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N Salvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Politis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Kaur.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not include any studies with human participants or animals done by any of the authors.

Informed consent

For this type of study, formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaur, J., Jacobs, R., Huang, Y. et al. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clin Oral Invest 22, 633–640 (2018). https://doi.org/10.1007/s00784-018-2337-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-018-2337-x

Keywords

Search

Navigation